Almokalant
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Almokalant is drug used to treat arrhythmia.[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.[2]
References
References
- ↑ Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). “Torsades de pointes with Almokalant, a new class III antiarrhythmic drug”. American heart journal. 126 (4): 1008–1011.
- ↑ Signs of Almokalant – Teratogenic Agent, wrongdiagnosis.com
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH